Robert M. Rifkin, MD, FACP

Medical Oncologist / Hematologist

Robert M. Rifkin, MD | Oncologist at Rocky Mountain Cancer Centers

Denver - Midtown

1800 N. Williams St., Ste. 200
Denver, CO 80218


Request an Appointment

Secondary Location(s)

Steamboat Springs

1100 Central Park Dr., Ste. 2000
Steamboat Springs, CO 80487


Request an Appointment

About Robert M. Rifkin, MD, FACP

Dr. Rifkin is a board-certified medical oncologist and hematologist specializing in malignant and benign hematology, treating blood cancers and disorders. He has an advanced sub-specialty expertise in coagulation disorders, multiple myeloma and biosimilars.

Dr. Rifkin practices evidence-based medicine and follows National Comprehensive Cancer Network (NCCN) guidelines for cancer treatment.

Advanced Practice Providers Working With Dr. Rifkin

Board Certifications

Internal Medicine
Medical Oncology


  • Benign and Malignant Hematology
  • Biosimilars
  • Bleeding Disorders
    • Thrombocytopenia
  • Blood Disorders
    • Anemia
    • Pregnancy-Related Blood Disorders
  • Clotting Disorders
  • Coagulation
  • Hereditary Hemochromatosis
  • Hodgkin's Lymphoma
  • Iron Deficiency
  • Leukemia
    • Acute Lymphoblastic Leukemia (ALL)
    • Acute Myeloid Leukemia (AML)
    • Chronic Lymphocytic Leukemia (CLL)
    • Chronic Myeloid Leukemia (CML)
  • Multiple Myeloma
    • Amyloidosis
    • Monoclonal Gammopathy (MGUS)
    • Smoldering Multiple Myeloma
  • Myeloid Malignancies
  • Myeloproliferative Neoplasms
    • Polycythemia Vera
    • Essential Thrombocytosis
    • Primary Myelofibrosis
  • Myelodysplastic Syndromes
  • Non-Hodgkin's Lymphoma
    • Diffuse Large B-Cell Lymphoma
    • Follicular Lymphoma
    • Peripheral T-Cell Lymphoma and Other T-Cell Lymphomas
  • Surgical Clearances



Medical Oncology & Hematology, University of Arizona Health Sciences Center, Tucson, AZ


Internal Medicine, Presbyterian St. Luke’s Medical Center, Denver, CO

Medical School

University of Colorado School of Medicine, Aurora, CO

Patient Care Philosophy

I stress continuity of care and access to state-of-the-art therapies and treatments. It’s essential to rapidly develop therapies and provide them to patients.

Around the Web

Additional Information

American Association for Cancer Research
American Association for the Advancement of Science
Association of Clinical Researchers and Educators
American Society for Blood and Marrow Transplantation
American Society for Histocompatibility and Immunogenetics
American Association of Blood Banks
American College of Physicians
American Society for Apheresis
American Society of Clinical Oncology
American Society of Clinical Pathology
American Society of Hematology
American Society of Therapeutic Radiology and Oncology
Colorado Medical Society
Denver Medical Society
Eastern Cooperative Oncology Group
International Myeloma Society
International Society for Cellular Therapy
International Society for Hematotherapy and Graft Engineering
International Society for Hemostasis and Thrombosis
National Patient Advocate Foundation/Patient Advocate Foundation, Colorado State Chair
National Patient Advocate Foundation/Patient Advocate Foundation, Executive Board of Directors
US Oncology, Hematology Executive Committee
US Oncology, Hematology Research Committee
US Oncology, Medical Lead – Biosimilars Task Force
US Oncology, Research Scientific Advisory Board